Anavex Life Sciences Corp. Profile Avatar - Palmy Investing

Anavex Life Sciences Corp.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial…

Biotechnology
US, New York [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of AVXL's Analysis
CIK: 1314052 CUSIP: 032797300 ISIN: US0327973006 LEI: - UEI: -
Secondary Listings
AVXL has no secondary listings inside our databases.